Einstein-Rockefeller-CUNY Center for AIDS Research

Clinical, Translational and Implementation Science Core

The overarching goal of the ERC-CFAR’s Clinical, Translational and Implementation Science Core (CTISC) is to provide a regional research platform to support the initiation and expansion of HIV-related clinical, translational and implementation research. The CTISC will assist researchers in participant recruitment for both clinical trials (e.g. eradication research or pathogenesis) and for observational studies by active recruitment of patients with rare phenotypes (e.g. elite or viremic controllers) for studies anywhere in the United States. It also provides support for research projects assessing policy, contextual, clinic/practice and individual factors impacting uptake and outcomes of delivered services, and access to and analysis of data from three databases.

The CTISC provides access to three robust clinical databases. The HIV Clinical Cohort, from the Montefiore/Einstein clinical services, contains demographic, clinical and laboratory data on over 18,000 HIV-infected and 420,000 HIV-negative patients. This dynamic, comprehensive, longitudinal database accesses Montefiore’s extensive clinical infrastructure to facilitate enrollment of well-characterized patients (including HIV-negative controls) into new research protocols. The Amida Care Cohort leverages the informatics resources of Amida Care, the largest Medicaid Special Needs Plan in NYS, with >6,000 PLWH in NYC. The Master Research Cohort has centralized data and specimen information from ~4700 participants in 31 funded research studies. With seed funding from Einstein, these three resources have stimulated many new clinical, implementation and translational investigations within Einstein, with the primary partners (Rockefeller and CUNY) and with other investigators in NYC and nationally. The maintenance of the HIV Clinical Cohort Database succeeds through collaboration with Einstein’s Institute for Clinical and Translational Research (ICTR), an NIH-funded site in the Clinical and Translational Science Awards (CTSA) program, and its integration into the ICTR’s Informatics Commons. CTISC maintains an infrastructure to facilitate recruitment and enrollment from all three cohorts into clinical trials, observational and translational studies requiring new specimens or special studies (e.g. functional MRI) in HIV-infected individuals with specified clinical characteristics.

  • Provide a clinical research platform to serve basic, clinical/epidemiologic, translational, behavioral and implementation science investigators in New York City or beyond.
    • Leverage our large patient population (18,000 PLWH, representing 150,000 person-years) seen since 1997 to catalyze new research and recruit participants for investigators conducting clinical trials or other studies.
    • Use state-of-the-art informatics provided through Einstein’s ICTR to maintain databases derived from Montefiore/Einstein’s integrated electronic health informatics system and Amida Care to support new investigations in diverse, underrepresented groups (e.g. women, pregnancy, MSM of color, HIV-exposed) through support in study design, biostatistics, database access and specimen collection.
    • Integrate with the ERC-CFAR’s Behavioral Science Core and the Scientific Working Groups (Eradication, Patient and Population Health Outcomes Research) to support the entire ERC-CFAR’s scientific goals.
  • Advance collaboration under the umbrella of implementation science
    • Support research to identify multi-level factors that influence timely and sustained achievement of HIV Care/Prevention Continuum outcomes (e.g. uptake of PrEP, early diagnosis, sustained viral suppression) in specific populations.
  • Support bench scientists in translational investigation (e.g. virologic, immunologic, genetic) studies
    • Provide human specimens, both through the existing research and clinical biorepositories (Master Research Cohort), and through rapidly sourcing, enrolling and consenting patients with specific characteristics, assisting in IRB approval, and supporting fresh specimen collection, transport and processing.
  • For further information, please contact our study coordinator, Ms. Madeline Torres, at ctisc-admin@einstein.yu.edu. 

Dr. Kathy Anastos
Director, ERC Clinical Translational and Implementation Science Core, Einstein
Professor, Medicine, Epidemiology & Population Health, Obstetrics & Gynecology and Women's Health
Co-Director, Global Health Center  

Dr. Marina Caskey
Associate Director, Clinical Research Studies
Assistant Professor, Clinical Investigation, Rockefeller
Member, Laboratory of Molecular Immunology


Dr. Howard Strickler
Associate Director, Epidemiologic Studies
Professor, Epidemiology & Population Health, Einstein
Harold and Muriel Block Chair, Epidemiology & Population Health
Division Head, Div of Epidemiology

Dr. Heidi Jones
Associate Director, Implementation Science
Associate Professor, Epidemiology, CUNY School of Public Health


Dr. Stephen Karpiak
Senior Director for Research, ACRIA Center on HIV and Aging at GMHC 

Dr. Uriel Felsen
Assistant Professor, Medicine (Infectious Diseases), Einstein 


Ms. Mindy Ginsberg
Senior Associate, Epidemiology & Population Health, Einstein
Director, Epidemiology, Informatics and Study Management Unit

Dr. David Hanna
Research Assistant Professor, Epidemiology & Population Health, Einstein 


Ms. Madeline Torres
Research Nurse and Study Coordinator, ERC Clinical Translational and Implementation Science Core, Einstein 


HIV Clinical Cohort Database

The HIV Clinical Cohort Database is an epidemiologic resource containing de-identified demographic, clinical, laboratory, prescription, and outcomes data on over 18,000 HIV-infected and 420,000 HIV-negative patients seen in the Montefiore Health System since 1997.

This dynamic, comprehensive, longitudinal database based on Montefiore’s extensive clinical infrastructure, including the Epic electronic medical record, serves two purposes:

  1. To facilitate the development of epidemiologic studies, including those focused on implementation science
  2. To serve as potential source of study participants for clinical studies.

Data cleaning and other quality assurance activities are conducted on datasets that are generated twice each year, with a focus on key HIV-related variables. Data dictionaries summarize the major variables that are maintained in the database. The database is managed by the Epidemiology Informatics and Study Management Unit (EISMU) of Albert Einstein College of Medicine, and all study activities are managed by the CTISC.

Our summary slides contain a detailed overview of the database and summary statistics for our populations.

To propose a project utilizing the HIV Clinical Cohort Database, please complete the Collaboration Concept Sheet Submission Form. Please direct all inquiries to the study coordinator at ctisc-admin@einstein.yu.edu.


Recent publications supported by the Clinical, Translational and Implementation Science Core


  • Grov C, Westmoreland DA, Carneiro PB, Stief M, MacCrate C, Mirzayi C, Pantalone DW, Patel VV, Nash D (2019).  Recruiting vulnerable populations to participate in HIV prevention research: Findings from the Together 5000 cohort study.  Ann Epidemiol 35: 4-11.  Pubmed 
  • Hanna DB, Ramaswamy C, Kaplan RC, Kizer JR, Daskalakis DC, Anastos K, Braunstein SL (2019).  Sex- and poverty-specific patterns in HIV-associated cardiovascular mortality in New York City, 2007-2017.  Clin Infect Dis, ePub 28 Aug 2019.  PMC Journal – In Process.  Pubmed 
  • Kong AM, Pozen A, Anastos K, Kelvin EA, Nash D (2019).  Non-HIV comorbid conditions and polypharmacy among people living with HIV age 65 or older compared with HIV-negative individuals age 65 or older in the United States: A retrospective claims-based analysis.  AIDS Patient Care STDs 33: 93-103.  Pubmed 
  • *Lankowski AJ, Bien-Gund CH, Patel VV, Felsen UR, Silvera R, Blackstock OJ (2019). PrEP in the real world: Predictors of 6-month retention in a diverse urban cohort. AIDS Behav 23: 1797-1802.  Pubmed 
  • McCarthy KJ, Gollub EL, Ralph L, van de Wijgert J, Jones H (2019). Hormonal contraceptives and the acquisition of sexually transmitted infections: An updated systematic review. Sex Transm Dis 46: 290-296.   Pubmed 
  • *Shitole SG, Srinivas V, Berkowitz JL, Shah T, Park MJ, Herzig S, Christian A, Patel N, Xue X, Scheuer J, Kizer JR (2019).  Hyperglycaemia, adverse outcomes and impact of intravenous insulin therapy in patients presenting with acute ST‐elevation myocardial infarction in a socioeconomically disadvantaged urban setting: The Montefiore STEMI Registry.  Endocrinol Diab Metab ePub 14 Aug 2019.


  • *Cossarini F, Hanna DB, Ginsberg MS, Blackstock OJ, Anastos K, Felsen UR (2018). Missed opportunities for HIV prevention: Individuals who HIV seroconverted despite accessing healthcare. AIDS Behav 22: 3519-3524.   Pubmed 
  • Dara JS, Hanna DB, Anastos K, Wright R, Herold BS (2018).  Low birth weight in human immunodeficiency virus-exposed uninfected infants in Bronx, New York.  J Ped Infect Dis Soc 7: e24-e29.  Pubmed 
  • Grov C, Jonathan Rendina H, Patel VV, Kelvin E, Anastos K, Parsons JT (2018).  Prevalence of and factors associated with the use of HIV serosorting and other biomedical prevention strategies among men who have sex with men in a US nationwide survey.  AIDS Behav 22: 2743-2755.  Pubmed 
  • Marhefka SL, Turner D, Lockhart E, Rivara A, Wang W, Shuter J (2018). Meeting our patients "where they are": Video-group smoking cessation for people living with HIV. J Assoc Nurses AIDS Care 29: 338-344.   Pubmed 
  • *Masyukova MI, Hanna DB, Fox AD (2018). HIV treatment outcomes among formerly incarcerated transitions clinic patients in a high prevalence setting. Health Justice 6: 16.   Pubmed 
  • Ross J, Cunningham CO, Hanna DB (2018). HIV outcomes among migrants living in high-income countries: a review of recent evidence. Curr Opin Inf Dis 31: 25-32.  Pubmed 
  • Watnick D, Keller MJ, Stein K, Bauman LJ (2018). Acceptability of a tenofovir disoproxil fumarate vaginal ring for HIV prevention among women in New York City. AIDS Behav 22: 421-436.   Pubmed 


  • *Bien CH, Patel VV, Blackstock OJ, Felsen UR (2017).  Reaching key populations: PrEP uptake in an urban health care system in the Bronx, New York.  AIDS Behav 5: 1309-1314.  Pubmed 
  • Flerin NC, Chen H, Glover TD, Lamothe PA, Zheng JH, Fang JW, Ndhlovu ZM, Newell EW, Davis MM, Walker BD, Goldstein H (2017). T-cell receptor (TCR) clonotype-specific differences in inhibitory activity of HIV-1 cytotoxic T-cell clones is not mediated by TCR alone. J Virol 91: e02412-16.   Pubmed 
  • Mesquita PMM, Preston-Hurlburt P, Keller MJ, Vudattu N, Espinoza L, Altrich M, Anastos K, Herold KC, Herold BC (2017). Role of interleukin 32 in human immunodeficiency virus reactivation and its link to human immunodeficiency virus-herpes simplex virus coinfection. J Infect Dis 215: 614-622.   Pubmed 
  • *Ross J, Felsen UR, Cunningham CO, Patel VV, Hanna DB (2017).  Outcomes along the HIV care continuum among undocumented immigrants in clinical care.  AIDS Res Hum Retroviruses 33: 1038-1044.  Pubmed 
  • *Ross J, Hanna DB, Felsen UR, Cunningham CO, Patel VV (2017).  Emerging from the database shadows: Characterizing undocumented immigrants in a large cohort of HIV-infected persons.  AIDS Care 12: 1491-1498.  Pubmed 
  • Veenstra M, Williams DW, Calderon TM, Anastos K, Morgello S, Berman JW (2017). CXCR7 mediates CD14+CD16+ monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS. J Leukoc Biol 102: 1173-1185.  Pubmed 


  • *Felsen UR, Bellin EY, Cunningham CO, Zingman BS (2014).  Development of an electronic medical record-based algorithm to identify patients with unknown HIV status.  AIDS Care 26: 1318-1325.  Pubmed 
  • *Hanna DB, Felsen UR, Ginsberg MS, Zingman BS, Beil RS, Futterman DC, Strickler HD, Anastos K (2016).  Increased antiretroviral therapy use and virologic suppression in the Bronx in the context of multiple HIV prevention strategies.  AIDS Res Hum Retroviruses 32: 955-963.  Pubmed 
  • Hanna DB, Ramaswamy C, Kaplan RC, Kizer JR, Anastos K, Daskalakis D, Zimmerman R, Braunstein SL (2016). Trends in cardiovascular disease mortality among persons with HIV in New York City, 2001-2012. Clin Infect Dis 63: 1122-1129.  Pubmed 
  • Kuniholm MH, Leach T, Lunievicz J, Olivo N, Anastos K, Vazquez Y, Brennan-Ing M, Karpiak SE, Alao O, Nash D, Ernst J (2015).  Hepatitis C direct acting antiviral therapies in a New York City HIV/AIDS Special Needs Plan: Uptake and barriers.  AIDS Pt Care STDs 29: 643-645.  Pubmed 
  • *Shitole SG, Kayo N, Srinivas V, Alapati V, Nordin C, Southern W, Christia P, Faillace RT, Scheuer J, Kizer JR (2016).  Clinical profile, acute care, and middle-term outcomes of cocaine-associated ST-segment elevation myocardial infarction in an inner-city community.  Am J Cardiol 117: 1224-1230.  Pubmed 

*Uses the HIV Clinical Cohort Database. 


Einstein Logo 

Rockefeller Logo 

CUNY Logo 


ERC-CFAR at a Glance

Partner Institutions 

  • Albert Einstein College of Medicine
  • Rockefeller University
  • The City University of New York (CUNY)


Total ERC-CFAR members

  • 183 Full members
  • 10 Affiliate members

CFAR member trainees funded by NIH K awards

  • 15 Full members

NIH Funding 

FY2015 OAR NIH AIDS FRB grants

$34,084,840 Total costs


New NIH AIDS grants awarded in FY2016

$7,345,645 Total annual costs


FY2014 non-AIDS NIH grants

$34,745,334 Total costs

Publications (first 6 months of 2016) 

Total Publications: 240

Publications multi-authored
by ERC-CFAR members: 91



Director: Dr. H. Goldstein



Directors: Dr. V. Prasad & Dr. C. Cunningham


Biomarkers & Advanced Technologies 

Directors: Dr. J. Berman & Dr. S. Almo


Behavioral Science 

Director: Dr. L. Bauman


Clinical Translational Implementation Science 

Director: Dr. K. Anastos


Scientific Working Groups 

HIV and Eradication 

Directors: Dr. G. Kalpana & Dr. M. Caskey


Patient and Population Health Outcomes Research 

Directors: Dr. D. Nash & Dr. J. Arnsten  

New 2016 NIH Grants Awards 

Click here to log in

In the Media

With Donor Backing, Hard-Hit Bronx Becomes a Center for COVID-19 Research

Harris Goldstein, M.D., discusses the challenge grant awarded to Einstein and Montefiore by Michael F. Price and the Price Family Foundation to support COVID-19 research. Dr. Goldstein is associate dean for scientific resources and professor of microbiology & immunology.

(Monday, Jul 13, 2020)

Now Made in New York City: Much-Needed Coronavirus Test Kits

Harris Goldstein, M.D., and Brian Pelowski discuss Einstein's success in transforming a lab to provide viral transport medium after the New York City Economic Development Corporation requested the college's assistance for its initiative to produce 50,000 COVID-19 testing kits each week. Dr. Goldstein is associate dean for scientific resources and Mr. Pelowski is assistant dean for scientific operations.

Additional coverage of the initiative includes CBS NewYork, US News & World Report, NBC 4 New York, ABC7NewYork, PIX11, AMNewYork, The Staten Island Advance, Patch, Gothamist, WCBS880, The Daily News, and The New York Post.

(Wednesday, Jun 10, 2020)

coverage on other stories